Axa S.A. Karyopharm Therapeutics Inc. Transaction History

Axa S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$14.15 - $17.19 $311,300 - $378,180	-22,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$14.14 - $19.71 $442,582 - $616,923	-31,300 Reduced 58.72%	22,000 $321,000
Q1 2020 May 15, 2020	BUY	$14.38 - $27.72 $766,454 - $1.48 Million	53,300 New	53,300 $1.02 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $67M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.